Human milk composition differs by maternal BMI in the first 9 months postpartum.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 17 11 2019
accepted: 16 04 2020
pubmed: 14 5 2020
medline: 26 9 2020
entrez: 14 5 2020
Statut: ppublish

Résumé

Studies indicate that maternal weight status modulates human milk composition; however, results are conflicting. Our objective was to examine the relation between maternal body composition and human milk macronutrients and bioactive components and also their association with infant daily intakes and body composition. Human milk samples were obtained from a longitudinal study (NCT01131117) in normal weight (NW: 18.5-24.9 kg/m2, n = 88) and overweight/obese (OW: 25-35 kg/m2, n = 86) women between 0.5 and 9 mo postpartum. Macronutrient content was estimated using mid-infrared spectroscopy. Leptin, insulin, and C-reactive protein (CRP) were measured using electrochemiluminescence immunoassays. Infant body composition was obtained using quantitative MRI. Linear mixed models were adjusted for postpartum age and infant sex. Human milk in OW mothers was higher in fat and protein and lower in carbohydrate content at some time points compared with that in NW mothers. Human milk leptin, insulin, and CRP concentrations were higher in OW mothers compared with NW mothers, with infants of OW mothers exposed to 1.5-2.5 times higher concentrations of leptin and insulin compared with infants of NW mothers. Similar results were observed when concentrations were normalized to infant daily intake and body weight. The effect sizes of infant daily intakes associated with infant growth parameters were small for macronutrients [0.005-0.05 z-score units and 0.02-0.45 fat mass index (FMI) or fat-free mass index units per unit of change in composition, P < 0.05]. Larger effect sizes were seen with human milk insulin and leptin (0.24 z-score units and 0.37-1.15 FMI units per unit of change in composition, P < 0.05). These findings demonstrate that infants of OW mothers are exposed to higher concentrations of insulin, leptin, and, to a lesser extent, CRP. The bioavailability of these 3 human milk bioactives and their mechanisms of action in the infant are unclear.This trial was registered at clinicaltrials.gov as NCT01131117.

Sections du résumé

BACKGROUND
Studies indicate that maternal weight status modulates human milk composition; however, results are conflicting.
OBJECTIVES
Our objective was to examine the relation between maternal body composition and human milk macronutrients and bioactive components and also their association with infant daily intakes and body composition.
METHODS
Human milk samples were obtained from a longitudinal study (NCT01131117) in normal weight (NW: 18.5-24.9 kg/m2, n = 88) and overweight/obese (OW: 25-35 kg/m2, n = 86) women between 0.5 and 9 mo postpartum. Macronutrient content was estimated using mid-infrared spectroscopy. Leptin, insulin, and C-reactive protein (CRP) were measured using electrochemiluminescence immunoassays. Infant body composition was obtained using quantitative MRI. Linear mixed models were adjusted for postpartum age and infant sex.
RESULTS
Human milk in OW mothers was higher in fat and protein and lower in carbohydrate content at some time points compared with that in NW mothers. Human milk leptin, insulin, and CRP concentrations were higher in OW mothers compared with NW mothers, with infants of OW mothers exposed to 1.5-2.5 times higher concentrations of leptin and insulin compared with infants of NW mothers. Similar results were observed when concentrations were normalized to infant daily intake and body weight. The effect sizes of infant daily intakes associated with infant growth parameters were small for macronutrients [0.005-0.05 z-score units and 0.02-0.45 fat mass index (FMI) or fat-free mass index units per unit of change in composition, P < 0.05]. Larger effect sizes were seen with human milk insulin and leptin (0.24 z-score units and 0.37-1.15 FMI units per unit of change in composition, P < 0.05).
CONCLUSIONS
These findings demonstrate that infants of OW mothers are exposed to higher concentrations of insulin, leptin, and, to a lesser extent, CRP. The bioavailability of these 3 human milk bioactives and their mechanisms of action in the infant are unclear.This trial was registered at clinicaltrials.gov as NCT01131117.

Identifiants

pubmed: 32401302
pii: S0002-9165(22)00827-9
doi: 10.1093/ajcn/nqaa098
pmc: PMC7458771
doi:

Banques de données

ClinicalTrials.gov
['NCT01131117']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-557

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK107516
Pays : United States

Informations de copyright

Copyright © The Author(s) on behalf of the American Society for Nutrition 2020.

Références

Early Hum Dev. 2019 Oct;137:104832
pubmed: 31422343
Arch Dis Child Fetal Neonatal Ed. 2003 May;88(3):F214-6
pubmed: 12719395
Nutrients. 2016 Jun 21;8(6):
pubmed: 27338468
Biol Neonate. 1999 Mar;75(3):143-51
pubmed: 9925901
BMC Public Health. 2014 Dec 13;14:1267
pubmed: 25495402
Adv Nutr. 2012 Sep 01;3(5):675-86
pubmed: 22983846
Int J Obes (Lond). 2018 Jan;42(1):36-43
pubmed: 28925410
Nutr Rev. 2018 Dec 1;76(12):875-892
pubmed: 30285146
Obesity (Silver Spring). 2016 Jun;24(6):1213-21
pubmed: 27151491
Am J Clin Nutr. 2007 Dec;86(6):1717-21
pubmed: 18065591
Nutrients. 2017 Mar 09;9(3):
pubmed: 28282925
Sci Rep. 2016 May 26;6:26789
pubmed: 27226415
Am J Clin Nutr. 2012 Apr;95(4):867-74
pubmed: 22378730
Am J Clin Nutr. 1993 Aug;58(2):152-61
pubmed: 8338041
Pediatrics. 2012 Mar;129(3):e827-41
pubmed: 22371471
Eur J Clin Nutr. 2016 Feb;70(2):250-6
pubmed: 26419197
Am J Hum Biol. 2012 Jul-Aug;24(4):533-40
pubmed: 22434662
Matern Child Health J. 2017 Jun;21(6):1367-1376
pubmed: 28138825
Am J Clin Nutr. 1991 Feb;53(2):457-65
pubmed: 1989413
PLoS One. 2016 Dec 22;11(12):e0168568
pubmed: 28005966
Acta Paediatr. 2016 Jun;105(6):641-7
pubmed: 26865238
Nestle Nutr Inst Workshop Ser. 2013;77:57-64
pubmed: 24107496
Nutrients. 2019 Jun 28;11(7):
pubmed: 31261649
Pediatr Obes. 2012 Aug;7(4):304-12
pubmed: 22577092
Breastfeed Med. 2012 Jun;7(3):179-88
pubmed: 22166069
Pediatr Obes. 2015 Feb;10(1):67-73
pubmed: 24729519
J Paediatr Child Health. 2013 Mar;49 Suppl 1:1-7
pubmed: 23448314
J Clin Endocrinol Metab. 1998 May;83(5):1810-3
pubmed: 9589698
Am J Clin Nutr. 2019 Dec 1;110(6):1370-1383
pubmed: 31589250
Am J Clin Nutr. 2014 Jun;99(6):1351-8
pubmed: 24622802
Pediatr Obes. 2017 Aug;12(4):304-311
pubmed: 27161761
Eur J Clin Nutr. 2017 Sep;71(9):1094-1100
pubmed: 28513622
Pediatr Obes. 2015 Aug;10(4):283-7
pubmed: 25291239
Obesity (Silver Spring). 2011 Oct;19(10):2089-95
pubmed: 21779094
Obesity (Silver Spring). 2017 Dec;25(12):2092-2099
pubmed: 28985033
Am J Clin Nutr. 2019 Jul 1;110(1):111-120
pubmed: 30968129
Nutrients. 2018 Sep 27;10(10):
pubmed: 30262786
J Dairy Sci. 1987 Aug;70(8):1557-62
pubmed: 3312320
J Matern Fetal Neonatal Med. 2018 May;31(10):1385-1388
pubmed: 28523959
Pediatr Obes. 2017 Aug;12 Suppl 1:78-85
pubmed: 28160457
J Hum Lact. 2015 May;31(2):209-12
pubmed: 25699683
Gut. 2002 Jun;50(6):797-802
pubmed: 12010881
Obesity (Silver Spring). 2019 Apr;27(4):621-628
pubmed: 30900412
Pediatr Obes. 2018 Oct;13(10):598-606
pubmed: 30092608
Dev Psychobiol. 1990 Sep;23(6):511-8
pubmed: 2272407

Auteurs

Clark R Sims (CR)

Arkansas Children's Nutrition Center, Little Rock, AR, USA.

Melissa E Lipsmeyer (ME)

Edward Via College of Osteopathic Medicine-Louisiana Campus, Monroe, LA, USA.

Donald E Turner (DE)

Arkansas Children's Nutrition Center, Little Rock, AR, USA.

Aline Andres (A)

Arkansas Children's Nutrition Center, Little Rock, AR, USA.
Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH